PepGen EPS History: Annual & Quarterly (PEPG)
PepGen's diluted EPS was -$2.12 for fiscal 2025.
View full PepGen company overviewPepGen annual diluted eps history
| Fiscal year | Period ended | Diluted EPS | Basic EPS | Change | Growth |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | -$2.12 | -$2.12 | $0.73 | — |
| 2024 | 2024-12-31 | -$2.85 | -$2.85 | $0.45 | — |
| 2023 | 2023-12-31 | -$3.30 | -$3.30 | $1.12 | — |
| 2022 | 2022-12-31 | -$4.42 | -$4.42 | $25.85 | — |
| 2021 | 2021-12-31 | -$30.27 | -$30.27 | — | — |
PepGen quarterly diluted eps
| Fiscal quarter | Period ended | Diluted EPS | Basic EPS | Change | YoY change |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$0.26 | -$0.26 | $0.44 | — |
| Q1 2026 | 2026-03-31 | -$0.26 | -$0.26 | $0.66 | — |
| Q4 2025 | 2025-12-31 | -$0.27 | -$0.27 | — | — |
| Q3 2025 | 2025-09-30 | -$0.52 | -$0.52 | $0.14 | — |
| Q2 2025 | 2025-06-30 | -$0.70 | -$0.70 | $0.17 | — |
| Q1 2025 | 2025-03-31 | -$0.92 | -$0.92 | -$0.29 | — |
| Q3 2024 | 2024-09-30 | -$0.66 | -$0.66 | $0.32 | — |
| Q2 2024 | 2024-06-30 | -$0.87 | -$0.87 | -$0.05 | — |
| Q1 2024 | 2024-03-31 | -$0.63 | -$0.63 | $0.06 | — |
| Q3 2023 | 2023-09-30 | -$0.98 | -$0.98 | -$0.19 | — |
| Q2 2023 | 2023-06-30 | -$0.82 | -$0.82 | $0.41 | — |
| Q1 2023 | 2023-03-31 | -$0.69 | -$0.69 | $18.25 | — |
| Q3 2022 | 2022-09-30 | -$0.79 | -$0.79 | $8.28 | — |
| Q2 2022 | 2022-06-30 | -$1.23 | -$1.23 | $4.80 | — |
| Q1 2022 | 2022-03-31 | -$18.94 | -$18.94 | -$11.52 | — |
| Q3 2021 | 2021-09-30 | -$9.07 | -$9.07 | — | — |
| Q2 2021 | 2021-06-30 | -$6.03 | -$6.03 | — | — |
| Q1 2021 | 2021-03-31 | -$7.42 | -$7.42 | — | — |
PepGen diluted eps trends
Between the periods ended 2021-12-31 and 2025-12-31, PepGen's diluted eps increased from -$30.27 to -$2.12, a change of $28.15. The latest reported quarter, Q2 2026, shows -$0.26.
What earnings per share (EPS) means
Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.
SEC-reported diluted and basic EPS
TickerStat displays diluted and basic earnings per share from SEC filings. Historical EPS values are adjusted to the current share basis when SEC-reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PepGen source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...